Oncology
12 Questions with Julia Jakl
Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles
A new paradigm for drug discovery: part three – online shopping for scientists: new tools for finding and engaging service vendors

A new paradigm for drug discovery: part three – online shopp...

In part three of four, Dr Kevin Lustig and Dr Maria Thompson discuss how new tools for engaging service vendors can accelerate your drug discovery program. It will come as no surprise to anyone reading this that the pharmaceutical industry is currently suffering from quite a few problems...

Articles
How doctors prefer to engage with pharma: part one

How doctors prefer to engage with pharma: part one

In this new series, we will be interviewing five oncologists from a range of different demographics to find out how they prefer to engage with pharma and how this could be improved in the futur

Articles
Patient perspectives: Penny Perez

Patient perspectives: Penny Perez

Penny Perez highlights the rare disorder of Williams syndrome by sharing her son, Keith’s, story. Penny’s son has a rare disorder known as Williams syndrome. In this Williams syndrome awareness month Penny discusses...

Sales & Marketing

Sales & Marketing
Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
12 Questions with Julia Jakl
Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Patients

R&D